Tirzepatide 45MG 03ML

CellGenic supports physicians, clinics, and qualified professionals with premium research products manufactured to rigorous quality standards. Our peptide portfolio is developed to meet the demands of advanced scientific and regenerative medicine research.

Tirzepatide 45mg/3mL is a dual-receptor peptide formulation studied for its interaction with both GIP and GLP-1 pathways. Ongoing research explores its role in metabolic regulation, energy utilization, appetite signaling, and glucose homeostasis. The peptide’s innovative mechanism has made it a widely recognized compound in contemporary metabolic research programs

🌍 Checking stock availability for your region…

Lot-traced  ·  COA on file  ·  Sterility & mycoplasma tested

Dose of Peptide

Strength of Peptide

Water of Peptide

Results

PEPTIDE DOSE: Select dose

DRAW SYRINGE TO: Select values

Injection Calculator Syringe

YOUR VIAL CONTAINS: Select values

CONCENTRATION: Select values

Metabolic Performance & Energy Balance

Tirzepatide has attracted significant scientific interest due to its ability to engage multiple metabolic pathways simultaneously. By targeting both GIP and GLP-1 receptors, researchers can investigate complex biological processes associated with nutrient metabolism and hormonal signaling.

Current studies focus on how these pathways may influence energy expenditure, metabolic efficiency, glucose processing, and body composition. Its dual-action profile continues to expand opportunities for advanced metabolic research.

Product specifications.

Format

Sterile Peptide Solution

Purity

Research Grade Quality

Vial sizes

45mg / 3mL

Storage

Refrigerate Upon Receipt

Reconstitution

Multi-Dose Liquid Vial

COA

Certificate of Analysis Available

Research Domains Tirzepatide Supports

Glucose Homeostasis

Studied for its involvement in pathways related to glucose utilization and insulin signaling.

Energy Metabolism

Research focuses on mechanisms associated with energy production and metabolic balance.

Appetite Signaling

Investigated for its interaction with biological pathways that regulate hunger and satiety.

Body Composition Research

Frequently included in studies examining weight-management mechanisms and metabolic adaptation.

Tirzepatide 45MG 03ML Faqs Questions:

Tirzepatide 45mg/3mL is a research peptide solution formulated to support studies involving dual GIP and GLP-1 receptor activity.
Its dual-receptor mechanism allows researchers to investigate multiple pathways involved in glucose regulation, energy metabolism, and appetite signaling.
This product combines a high-concentration liquid format with the established dual-incretin properties of Tirzepatide.
Research applications include metabolic function, glucose homeostasis, body composition studies, and energy-balance investigations.
CellGenic products are supplied exclusively to verified providers, clinics, physicians, and qualified research professionals.

Related Products

MSC · 50M cells/vial

Cellgenic MSC 50 millions

Box of 50M cells

Cellgenic MSC — Cord Blood Derived

MUSE· 20M cells/vial

Cellgenic MUSE 20 millions

Verified providers unlock pricing, COAs, and the full catalog.

Apply once, get reviewed by our team, and access provider-only pricing across peptides, exosomes, and cellular products.

Regulatory disclaimer

PRODUCT USAGE: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product is intended strictly for laboratory research and qualifies under appropriate regulatory frameworks for research-only use. It is not intended to diagnose, treat, cure, or prevent any disease or condition. This product should only be handled by licensed, qualified professionals. It is not intended for use by the general public. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

Cart Gated

Cart is provider-gated. Log in to view.

Provider Login →